On September 17, Snowflake rose 3.01% in regular trading, trading at $341.42/share, with turnover of $262 million. The stock extended its low-level rebound for a second consecutive session after weeks of selling pressure from concentrated insider disposals.

Multiple directors and executives had collectively sold over 168,000 shares worth nearly $60 million in recent weeks, dragging the stock well below its post-earnings highs. However, the latest filing from Director Frank Slootman to sell approximately 8,191 shares worth roughly $2.6 million was notably smaller in scale, suggesting the intensity of insider liquidation is fading.

Underpinning the recovery is Snowflake's strong fiscal Q2 performance, with product revenue growing 37% year-over-year and full-year product revenue guidance raised to $6.07 billion from $5.84 billion. Wall Street responded with a wave of target price upgrades, with firms including Morgan Stanley ($470), Bank of America ($470), UBS ($500), and Oppenheimer ($475) signaling significant upside. Options market activity also reflected bullish sentiment, with a $510,000 out-of-the-money call bet targeting a return above $350.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)